Fibrotic processes associated with long-term ergotamine therapy.
D000328:Adult; D004878:Ergotamine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010493:Pericarditis / Q000139:chemically induced; D010995:Pleural Diseases / Q000139:chemically induced*; D011658:Pulmonary Fibrosis / Q000139:chemically induced*
D004878:Ergotamine